GIST is an acronym that stands for gastrointestinal stromal tumor. This type of cancer starts in interstitial cells of Cajal (ICCs), which are special cells that line the walls of the ...

Most advanced gastrointestinal stromal tumors (GISTs) start with cancer-causing cell changes, or mutations, in specific genes. Changes in proteins called KIT and PDGFRA most commonly cause this ...

A gastrointestinal stromal tumor (GIST) is a cancerous tumor that grows in the digestive tract. Surgery can help remove the entire tumor. There are several procedures, including laparoscopy or ...

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the GI tract, arising from the interstitial cells of Cajal, primarily in the stomach and small intestine.

If you have advanced gastrointestinal stromal tumor (GIST), you may not know anyone else with the disease. This may leave you with a lot of questions about what life will be like with this rare ...

GISTs are a rare type of cancer that develops in the digestive tract’s connective tissue, specifically from cells that help regulate muscle contractions. GISTs are primarily driven by genetic ...

Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

The C2 subtype, defined as CD8 + inflamed, comprises high-risk intestinal GISTs with high infiltration of immune cells, especially CD8 + T cells, suggesting that these tumors may benefit from a ...

Huntsman Cancer Institute’s Sarcoma Service has a specialist team that treats soft-tissue sarcomas that form in the abdomen. Here are some soft-tissue sarcomas of the abdomen: Gastrointestinal stromal ...

This is the second highest number after thyroid cancer.Gastric cancer refers to a malignant tumor in the stomach, mainly ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these ...